Population Pharmacokinetics Analysis of Regorafenib and Its Active Metabolites From the Phase III Correct Study of Metastatic Colorectal CancerZuzana Jirakova Trnkova, Eric Van Cutsem, Alfredo Falcone et al.|Annals of Oncology|2013Cited by 7
O-0023 Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (mCRC)Alberto F. Sobrero, Dirk Laurent, Axel Grothey et al.|Annals of Oncology|2012Cited by 2